Once again, Precision BioLogic is pleased to support the World Federation of Hemophilia (WFH) and World Hemophilia Day. This year, the WFH is bringing attention to the women and girls who live with a bleeding disorder or has someone in their lives who does. Those affected by bleeding disorders are invited to join the conversation April 17 by sharing their story at www.worldhemophiliaday.org.
Tom Lynch, Chair of Precision BioLogic’s Board of Directors, is pleased to announce the appointment of Paul Empey as President and CEO of the company.
Thrombosis is responsible for one in four deaths worldwide, but the good news is that many, if not most cases, are preventable. That’s why it’s important to know if you are at risk and learn what you can do to help keep life flowing. Precision BioLogic is proud to support World Thrombosis Day and help the International Society on Thrombosis and Haemostasis (ISTH) increase global awareness of thrombosis. Here are five things you should know about thrombosis...
Precision BioLogic Becomes First Diagnostics Company to Commit to Supporting the World Federation of Hemophilia Humanitarian Aid Program:
Precision BioLogic and the World Federation of Hemophilia Collaborate to Bring Diagnostics Support to Cameroon
At the recent THSNA summit in Chicago, Precision BioLogic presented a poster summarizing the variability seen in measuring recombinant factor IX Fc fusion protein (rFIXFc) in the one-stage clotting assay.
April 24 to 30 marks a week to celebrate the vital contribution that medical laboratory professionals make to healthcare.
Precision BioLogic applauds the often behind-the-scenes work of this special group of professionals and is pleased to host a free, educational webinar.
Precision BioLogic is pleased support the World Federation of Hemophilia (WFH) mark World Hemophilia Day. This year, the WFH is focused on bringing attention to a challenge that too many people in the bleeding disorder community face: lack of access to diagnosis, treatment and care.
Heading to Chicago for THSNA April 14-16? If so, we’d love to see you. Drop by and visit us at Booth 117.
And, be sure to check out our live poster presentation Friday at 3:30 - 5:00 pm:
Recombinant Factor IX Fc Fusion Protein (rFIXFc) Clotting Activity Assessment in International Hemophilia Treatment Centers (Poster 34)
F. Jon Geske, Ali Sadeghi-Khomami
The Precision BioLogic poster Assessment of clotting activity of recombinant factor IX Fc fusion protein (rFIXFc) in plasma samples at haemophilia treatment centres in Australia and New Zealand was presented at the 17th Australian & New Zealand Conference on Haemophilia & Related Bleeding Disorders organized by HFA (October 1 to 3, Gold Coast, Australia) and the annual scientific meetings of the HAA (October 18 to 21, Adelaide, Australia).
One in four deaths worldwide is related to thrombosis, the formation of potentially deadly blood clots. Recognized annually on October 13, World Thrombosis Day places a global spotlight on thrombosis as an urgent and growing health problem through hundreds of educational events in countries around the world.
Peter Conlon, Chair of Precision BioLogic’s Board of Directors, is pleased to announce the appointment of Paul Empey as Executive Vice President of the company.
At the recent ISTH 2015 Congress in Toronto, Precision BioLogic presented two posters. We’re pleased to provide them here in a smaller format suitable for downloading.
Heading to Toronto for ISTH June 20-25? If so, we’d love to see you. Drop by and visit us at Booth 1610.
And, be sure to check out our posters Monday from 5:15 to 6:30 pm.